Contents & References of Relative frequency of metallobetalactamase enzyme in Pseudomonas aeruginosa strains isolated from clinical samples in Yazd city by E Test method
List:
Chapter One: Introduction and review of similar studies. 1
1-1- Pseudo family and Monadaceae 2
1-2- History of P. aeruginosa. 3
1-2-1- Morphological characteristics of P. aeruginosa. 5
1-2-2- growth characteristics. 5
1-2-3- Obligate aerobes 5
1-2-4- Cultivation specifications. 6
1-2-5- Required organic materials 7
1-2-6- Cultivation environments. 8
1-2-7- Pigman. 9
1-2-8- Pathogenicity indicators in P. aeruginosa. 11
1-2-8-1- Pili 11
1-2-8-2- Alginate 12
1-2-8-3- Endotoxin. 12
1-2-8-4- extracellular proteases. 13
1-2-8-5-hemolysins 15
1-2-8-6-phospholipase C. 15
1-2-8-7-rhamnolipids 15
1-2-9- extracellular toxins. 16
1-2-9-1- exotoxinA. 16
1-2-9-2- exoenzyme S. 16
1-2-10- high molecular weight leukocidin. 17
1-2-11- Siderophores 17
1-2-12- Lipase 17
1-2-13- Cytotoxin 18
1-2-14- Pyocyanin 18
1-2-15- Type III secretion system 18
1-2-16- Epidemiology. 19
1-2-17- Diseases caused by P. aeruginosa. 20
1-2-17-1- Bacteremia. 20
1-2-17-2- Ear infections. 20
1-2-17-3- eye infections. 21
1-2-17-4- Respiratory tract infections. 21
1-2-17-5- Bone and joint infections. 22
1-2-17-6- central nervous system infections. 22
1-2-17-7- Gastrointestinal tract infections. 22
1-2-17-8- Skin and soft tissue infections. 23
1-2-17-9- Infections of the administrative system. 24
1-2-17-10- Bacteremia. 24
1-2-17-11- Bone and joint infections. 24
1-2-17-12- central nervous system infections. 24
1-2-17-13- Infective endocarditis. 25
1-2-17-14- Respiratory tract infections. 25
1-2-17-15- Skin and soft tissue infection. 26
1-2-17-16- Urinary infections. 26
1-2-18- Metallobalactamase 27
1-2-19- Prevalence of metallobalactamases resistance 27
1-2-20- Types of metallobalactamase 28
1-2-21- The Imipenemase(IMP) Type 28
1-2-22- The Veronese Imipenemase (VIM) Type 28
1-2-23- New Delhi Metalo ?-lactamase-1 (NDM-1) Type 28
1-2-24- other types of metallobetalactamase 29
1-2-24-1- methods of detection of metallobetalactamase 29
1-2-24-2- Sensitivity test (antibiogram) 29
1-2-24-3- E.Test method by MBL strip. 30
A review of past studies. 31
Chapter Two: Materials and Methods 34
2-1 State the issue and the importance of the issue. 35
2-2- Objectives. 36
2-2-1- The main objectives of the plan. 36
2-2-2- Special objectives of the plan. 36
2-3- Questions and assumptions. 36
2-4- Study type and method. 37
2-5- Working method 37
2-5-1- Types of cultivation environment. 37
2-5-2- Mac Conkey agar 37
2-5-3- SIM culture medium. 38
2-5-4- Preparation method of Coax reagent for indole test. 39
2-5-5- OF culture medium. 39
2-5-6- TSI culture medium 39
2-5-7- Simon citrate medium. 40
2-5-8- Liquid medium (MR-VP. 40
2-5-9- How to prepare VP reagent. 41
2-5-10- How to prepare MR reagent. 41
2-5-11- Oxidase test 41
2-6- How to perform work 42
2-6-1- Collection of samples 2-6-2- Determination of metallobalactamase 43- 2-6- Statistical analysis 44- 2-6- Implementation problems 44- 2-7- Table of variables 45- Chapter 3: Findings 46- 3- Results. 47
Discussion, 1-4
4-References 75
Appendix
[1]. St.Louis: 2013. [2] Review of Microbiology. 1999. Saunders company
[3].Norouzi,J.General Bacteriology.1 the Edition.Jafari Tehran.Medical Microbiology, 21 the ed, Appleton and Longe. 2013 99
[5].
[6].Kean HF, Grekword. Eited in epidemiology of Pseudomonas aeruginosa bus infections. views of infectious diseases. 1984; 16 (3): 627-642.
[7]. Kean HF, Grekword, Eited in epidemiology of Pseudomonas aeruginosa bus infections. Views of infectious diseases. 1984; 16 (3): 645-667.
[8]. O'Leary, WM. Particle handbook of microbiology. CRC press, Boca Raton, Florida. 1989; 55-66.
[9]. Amoozegar MA, Akbari K. Biology. 3rd ed. Tehran: Pouran Pajohesh 2007: 429
[10]. Galli ES, Witholt B. Pseudomonas, molecular biology and biotechnology. American Society for Microbiol. Washington DC. 1992: 1-40. [11]. Sabath LD. Pseudomonas aeruginosa: the organism, diseases it causes and their treatment. Ed., Sabath, L.D. Hons Huber publisher, Bern. Switzerland. 1980:15-24.
[12]. Govan JRW. practical medical microbiology. Mackie and Mcqrtney, Churchill Livingston, London. 1990: 491-504 [13]. Palleroni NJ. Practical handbook of microbiology. Cd., O'Leary, W.M., Boca Raton. Florida. 1989: 104
[14].Mosavi R, Mahbod A, Mohamadi M, Hamidi fard M. PAS (Practical Approach Series). Tehran: Mir 2007:496
[15].Reimer A, Edvaller B, Johansoon B. Concentrations of the Pseudomonas aeruginosa toxin pyocyanin ear secretions. Acta-Otolaryngol-suppl. 2000;543: 86-88
[16].Schalk IJ, Hennard C, DugaveC, Poole K, Abdallah MA, Pattus F. Iron free pyoverdin binds to its outer membrane receptor FPVA in Pseudomonas aeruginosa a new mechanism for membrane iron transport. Mol Microbiol. 2000; 39 (2): 357-60
[17]. Branng P, Pearson JP, Pesci CE, Kohler T, Iglewski BH, Von-Delden C. Inhibition of quorum sensing by a Pseudomonas aeruginosa dks A homologue. J Bacteriol. 2001; 183(5): 1531-39
[18]. Van-Delden C, Comte R, Bally AM. Stringent response activates quorum sensing and modulates cell density-dependent gene expression in Pseudomonas aeruginosa. J Bacteriol. 2001; 183 (18): 5376-84
[19]. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist Microbes and Infection 2000; 2 (9): 1051-60
[20].Nagono T, Hao LJ, Nakamur M, Abe M, Nokazawa T, Nishida T. Stimulatory effect of Pseudomonas elastase on collagen degradation by cultured keratocytes. Invest-Ophthalmol-vis-sci. 2001; 42 (6): 1247-53
[21]. Chance CL, Mawhinney TP. Carbohyrate sulfation effects on growth of Pseudomonas aeruginosa, Microbiology. 2000; 146 (7): 1717-25
[22]. Mavrodi DV, Blankenfeldt W, Thomashow LS. Phenazine compounds in fluorescent Pseudomonas spp. biosynthesis and regulation. Annu Rev Phytopathol 2006; 44: 417-445
[23]. FrajadianS, Kaviani MJ, Ghader A, Molecular analysis of Pseudomonas aeruginosa isolated from hospitalized patients in Shiraz Iran. J med. 1996; 21 (3-4): 118 [24]. Colmer JA, Hmood AN. Characterization of Pseudomonas aeruginosa gene which interferes with the effect of the exotoxin A positive regulatory gene, PTX R. MOL Gene Genet. 1998;258:250-9
[25]. Stover CK, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1 on opportunistic pathogen. Nature. 2000; 406 : 959-64
[26]. Timothy RW, Mark AT, Patrice N. Metallo beta lactamases: the quiet before the storm. Clinical Microbiology Reviews. 2005; 18: 306-325
[27]. Surveillance initiative,. Postgrad Med. 2001–2005; 120(3 Suppl 1): 8-15
[28].Scoulica EV, Neonakis IK, Gikas AI, Tselentis YJ. Spread of blaVIM-1-producing E. coli in a university hospital in Greece: genetic analysis of the integron carrying the blaVIM-1 metallo-b-lactamase gene. Diagn Microbiol Infect Dis. 2004; 48:167–72
[29].
[30].Shibata N, Doi Y, Yamane K, Yagi T, Kurokawa H, Shibayama K, et al.